
The tobacco cembranoid (1S,2E,4S,7E,11E)-2,7,11-cembratriene-4,6-diol as a novel angiogenesis inhibitory lead for the control of breast malignancies
Keywords: Angiogenesis; Breast cancer; FAK; Paxillin; Tobacco cembranoids; VEGFR2;